MJN Neuroserveis, a CataloniaBio & HealthTech member, has obtained the CE mark certification for a non-invasive medical device to help people with epilepsy improve their quality of life, together with the notified body BSI Group.
"We have achieved the most important milestone of the project, the certification for commercialization in Europe. The entire MJN team would like to express our gratitude to all the people and entities that have helped us" says Salva Gutiérrez, co-founder and CEO-CFO at MJN.
In the coming months, MJN will launch the medical device on the market: in Spain through its websitemjn.cat/en and in the rest of Europe they are negotiating distribution agreements.
El equipo de investigadores observó cambios en el...
El gen AtCDF3 promueve una mayor producción de az...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del si...
Investigadores del Cima Universidad de Navarra constatan que la combin...
